Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

S. M. Rowe, J. B. Zuckerman, D. Dorgan, J. Lascano, K. McCoy, M. Jain, M. S. Schechter, S. Lommatzsch, V. Indihar, N. Lechtzin, K. McBennett, C. Callison, C. Brown, T. G. Liou, K. D. MacDonald, S. Z. Nasr, S. Bodie, M. Vaughn, E. B. Meltzer, A. J. Barbier

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study'. Together they form a unique fingerprint.

Medicine & Life Sciences